AKR7A3 and hepatocellular carcinoma: Loss of heterozygosity analysis on HCC patient DNA samples revealed the frequent deletion of AKR7A3, indicated by the high percentage of patients having allele loss in HCC tissue (43% of AKR7A3 down-regulated HCC samples showed LOH; Table 3).